About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
ANI PHARMACEUTICALS INC (ANIP): Insider Trades and Fund Holdings
In the past 12 months, ANI PHARMACEUTICALS INC insiders reported no open-market purchases and 15 sales worth $2.85M; 14 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 15, 2026Insider saleCEO Nikhil Lalwani sold $388,206 under a 10b5-1 plan
- Oct 15, 2026Planned saleNIKHIL LALWANI (director, officer) filed notice to sell about $378,864 around Oct 15, 2026
- Oct 13, 2026Insider saleGeneral Counsel Meredith Cook sold $36,795 under a 10b5-1 plan
- Sep 29, 2026Insider saleCFO Stephen P. Carey sold $208,050 under a 10b5-1 plan
- Sep 15, 2026Insider saleCEO Nikhil Lalwani sold $383,400 under a 10b5-1 plan
- Sep 15, 2026Planned saleNIKHIL LALWANI (director, officer) filed notice to sell about $380,160 around Sep 15, 2026
- Sep 14, 2026Insider saleGeneral Counsel Meredith Cook sold $35,395 under a 10b5-1 plan
- Sep 11, 2026Insider saleDirector Jeanne Thoma sold $71,530 under a 10b5-1 plan
- Sep 11, 2026Planned saleJEANNE THOMA (director) filed notice to sell about $71,460 around Sep 11, 2026
- Aug 31, 2026Insider saleCFO Stephen P. Carey sold $207,480 under a 10b5-1 plan (7 days after: executive or director change)
- Aug 25, 2026Insider saleCEO Nikhil Lalwani sold $401,220 under a 10b5-1 plan (1 days after: executive or director change)
- Aug 25, 2026Planned saleNIKHIL LALWANI (director, officer) filed notice to sell about $400,518 around Aug 25, 2026
- Aug 24, 2026NewsCompany reported: Executive or director change
- Aug 13, 2026Insider saleGeneral Counsel Meredith Cook sold $37,740 under a 10b5-1 plan
- Aug 10, 2026Insider saleSVP Ori Gutwerg sold $243,474
- Jul 29, 2026Insider saleCFO Stephen P. Carey sold $231,876 under a 10b5-1 plan
- Jul 13, 2026Insider saleGeneral Counsel Meredith Cook sold $40,920 under a 10b5-1 plan
- Jul 2, 2026Insider saleCFO Stephen P. Carey sold $284,918 under a 10b5-1 plan
- Jun 30, 2026FundRenaissance Technologies cut 66% in Q2 2026 (13F filed Aug 13, 2026)
- Jun 29, 2026Insider saleCFO Stephen P. Carey sold $239,742 under a 10b5-1 plan
- Jun 12, 2026Insider saleGeneral Counsel Meredith Cook sold $41,015 under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 16 | Nikhil LalwaniCEO | ▼ SELL10b5-1 | $388K |
| Oct 13 | Meredith CookGeneral Counsel | ▼ SELL10b5-1 | $37K |
| Sep 30 | Stephen P. CareyCFO | ▼ SELL10b5-1 | $208K |
| Sep 16 | Nikhil LalwaniCEO | ▼ SELL10b5-1 | $383K |
| Sep 14 | Jeanne ThomaDirector | ▼ SELL10b5-1 | $72K |
| Sep 14 | Meredith CookGeneral Counsel | ▼ SELL10b5-1 | $35K |
| Sep 1 | Stephen P. CareyCFO | ▼ SELL10b5-1 | $207K |
| Aug 26 | Nikhil LalwaniCEO | ▼ SELL10b5-1 | $401K |
| Aug 13 | Meredith CookGeneral Counsel | ▼ SELL10b5-1 | $38K |
| Aug 11 | Ori GutwergSVP | ▼ SELL | $243K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Nikhil Lalwani | CEO | 0 | $0 | 3 | $1.17M |
| Meredith Cook | General Counsel | 0 | $0 | 5 | $192K |
| Stephen P. Carey | CFO | 0 | $0 | 5 | $1.17M |
| Jeanne Thoma | Director | 0 | $0 | 1 | $72K |
| Ori Gutwerg | SVP | 0 | $0 | 1 | $243K |
Buybacks and executive pay
ANI PHARMACEUTICALS INC spent $12.2 million buying back its own shares in 2025.
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
A All 15 insider trades reported on time. How it is graded
Tracked funds that report ANIP
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 63,700 | $5.27M | ▼ −65.8% |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →